Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Share issues and offer TO2
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Feb 19 2021
Year-end report
Feb 25 2021
SciBase's US Partner study shows COVID-19 delaying skin cancer diagnosis
Mar 09 2021
SciBase announces a Management team change
Dec 08 2020
New Study published validating further Nevisense indication, Non-melanoma Skin Cancer
Feb 03 2021
The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2021:
Feb 05 2021
Further Study supports use of Nevisense within new Non-melanoma Skin Cancer application
Nov 02 2020
Positive step for US reimbursement of Nevisense
Nov 04 2020
SciBase announces changes to the Management team
Nov 12 2020
Interim report
Oct 02 2020
Exercise price for warrants of series TO1 in SciBase Holding AB determined and the subscription period commence on 5 October 2020
Pagination
First page
Previous page
…
Page
19
Page
20
Page
21
Page
22
Current page
23
Page
24
Page
25
Page
26
Page
27
…
Next page
Last page
Subscribe to
Close popup
Left
Right
